Cargando…

Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer

Chromosome maintenance region 1 (CRM1) also called Exportin 1 (Xpo1), a protein found elevated in pancreatic ductal adenocarcinoma (PDAC), blocks tumor suppressor protein (TSP) function through constant nuclear export. Earlier we had shown that targeting CRM1 by our newly developed specific inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jiankun, Azmi, Asfar S., Aboukameel, Amro, Kauffman, Michael, Shacham, Sharon, Abou-Samra, Abdul-Badi, Mohammad, Ramzi M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116494/ https://www.ncbi.nlm.nih.gov/pubmed/24899509

Ejemplares similares

Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition
por: Azmi, Asfar S., et al.
Publicado: (2015)

Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone
por: Muqbil, Irfana, et al.
Publicado: (2016)

Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death
por: Kashyap, Trinayan, et al.
Publicado: (2016)

Nuclear Export Inhibition for Pancreatic Cancer Therapy
por: Muqbil, Irfana, et al.
Publicado: (2018)

Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
por: Sexton, Rachel, et al.
Publicado: (2019)

Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells
por: Uddin, Md. Hafiz, et al.
Publicado: (2021)

Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
por: Azmi, Asfar S., et al.
Publicado: (2017)

Specific Inhibition of the Nuclear Exporter Exportin-1 Attenuates Kidney Cancer Growth
por: Wettersten, Hiromi I., et al.
Publicado: (2014)

Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer
por: Mendonca, Janet, et al.
Publicado: (2014)

Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms
por: Balasubramanian, Suresh Kumar, et al.
Publicado: (2022)

Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model
por: Muqbil, Irfana, et al.
Publicado: (2019)

DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma
por: Azmi, Asfar S., et al.
Publicado: (2019)

A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds
por: Crochiere, Marsha L., et al.
Publicado: (2015)

Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
por: Gravina, Giovanni Luca, et al.
Publicado: (2017)

Splicing promotes the nuclear export of β-globin mRNA by overcoming nuclear retention elements
por: Akef, Abdalla, et al.
Publicado: (2015)

Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression
por: Aboukameel, Amro, et al.
Publicado: (2018)

Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo
por: Kashyap, Trinayan, et al.
Publicado: (2021)

Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
por: Etchin, J, et al.
Publicado: (2013)

Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
por: Gravina, Giovanni Luca, et al.
Publicado: (2019)

Heterozygous mutation of cysteine(528) in XPO1 is sufficient for resistance to selective inhibitors of nuclear export
por: Neggers, Jasper Edgar, et al.
Publicado: (2016)

Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines
por: Breit, Megan N, et al.
Publicado: (2014)

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin
por: De Cesare, Michelandrea, et al.
Publicado: (2015)

Sequence Determinants for Nuclear Retention and Cytoplasmic Export of mRNAs and lncRNAs
por: Palazzo, Alexander F., et al.
Publicado: (2018)

The hnRNP C proteins contain a nuclear retention sequence that can override nuclear export signals
Publicado: (1996)

SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status
por: Al-Katib, Ayad M, et al.
Publicado: (2009)

Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185
por: Tabe, Yoko, et al.
Publicado: (2015)

Nuclear Export of L-Periaxin, Mediated by Its Nuclear Export Signal in the PDZ Domain
por: Shi, Yawei, et al.
Publicado: (2014)

Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals
por: Fung, Ho Yee Joyce, et al.
Publicado: (2017)

An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals
por: Mohammad, Ramzi M, et al.
Publicado: (2009)

Nuclear Imprisonment: Viral Strategies to Arrest Host mRNA Nuclear Export
por: Kuss, Sharon K., et al.
Publicado: (2013)

Reconstitution of nuclear protein export in isolated nuclear envelopes
por: Siebrasse, Jan Peter, et al.
Publicado: (2002)

Nuclear Export of Messenger RNA
por: Katahira, Jun
Publicado: (2015)

XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
por: Gravina, Giovanni Luca, et al.
Publicado: (2014)

Selective inhibitors of nuclear export avert progression in preclinical models of inflammatory demyelination
por: Haines, Jeffery D., et al.
Publicado: (2015)

mRNAs are sorted for export or degradation before passing through nuclear speckles
por: Fan, Jing, et al.
Publicado: (2018)

Fbw7 dimerization determines the specificity and robustness of substrate degradation
por: Welcker, Markus, et al.
Publicado: (2013)

Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers
por: Khan, Husain Yar, et al.
Publicado: (2022)

Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export
por: Duan, Lauren, et al.
Publicado: (2022)

Calreticulin Is a Receptor for Nuclear Export
por: Holaska, James M., et al.
Publicado: (2001)

Optogenetic control of nuclear protein export
por: Niopek, Dominik, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uhapq6le77918p5708or9lsjar